News for Ocuphire Pharma, Inc. (OCUP)

Board Timed Highly Dilutive Financing to Close on the Record Date for the Annual Meeting, Tilting the Vote and Forcing the Withdrawal of the Restore Value Slate

Board Comments on Misguided Campaign from Mina Sooch to Replace a Majority of Opus' Directors and Promote a Flawed Strategy Urges Stockholders to Vote on the B

**media[587786]**

Believes that Current Board's Strategic, Management and Capital Allocation Failures have Resulted in Stockholder Value Destruction Highlights Serious Concerns

Current Board's Strategic, Management, and Capital Allocation Failures Have Driven an 80% Stock Decline Over Last 22 Months New Leadership is Urgently Needed t

Stocks Analysis by Professor Ari Zoldan covering: General Motors Company, Dell Technologies Inc, Wells Fargo & Company, Wolfspeed Inc. Read Professor Ari Zoldan's latest article on Investing.com

**media[443996,443997]**

Published data from two Phase 3 clinical trials demonstrated rapid reversal of pharmacologically-induced mydriasis with favorable safety profile...

UPDATE “ Ocuphire Pharma Initiates VEGA-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% for Presbyopia

Top-line data from VEGA-3 Phase 3 trial expected in first half of 2025 Top-line data from LYNX-2 Phase 3 trial in patients with decreased visual acuity...

Ocuphire shares price target cut, buy rating held on FDA approval milestone

Ocuphire Pharma (OCUP) delivered earnings and revenue surprises of -3.45% and 38.22%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

CEO to participate in ARVO SIG panel on oral medications for retinal diseases ZETA-1 Phase 2 clinical trial subset analysis to be presented during the...

Stocks Analysis by The Tokenist (Timothy Fries) covering: Pfizer Inc, Ocuphire Pharma Inc, Rocket Pharmaceuticals Inc, Arvinas Inc. Read The Tokenist (Timothy Fries)'s latest article on Investing.com

Loading... Loading... The Dow Jones index closed higher by 0.2% on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern aro...

In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds.

The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.00 A.M. ET)..

Read Ocuphire Pharma (NASDAQ:OCUP) & TetraLogic Pharmaceuticals (OTCMKTS:TLOG) Head to Head Review at ETF Daily News

Read Research Analysts’ Upgrades for May 19th (AAVMY, AAWW, AIT, AMOT, AMRN, AMZN, ATO, BCH, BCS, BECN) at ETF Daily News